3PBIOVIAN
Mika Virtanen is an accomplished IT professional with extensive experience in various roles across multiple organizations. Currently serving as Head of IT at 3PBIOVIAN since February 2024, following the merger of Biovian and 3P Biopharmaceuticals, Mika was also Head of IT at Biovian earlier in 2024, overseeing comprehensive IT functions and cybersecurity strategies. Prior to these roles, Mika held significant positions at Lowell as Group Head of IT Service Delivery and IT Service Delivery Manager, leading IT services for over 4,000 users across multiple regions. Mika's career includes vital contributions at Lindorff Oy in various IT management roles, as well as entrepreneurial ventures in IT consulting and development. Education includes a Master of Science in Global IT Management from the University of Turku and a Bachelor’s Degree in Information System Design from Turku University of Applied Sciences.
This person is not in any teams
This person is not in any offices
3PBIOVIAN
3PBIOVIAN service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production, with the provision for fill and finish services for recombinant proteins and viral vectors. Leveraging a combined track record of 40 years in process development and analytical methods development, complemented by the experience in process scale-up, GMP manufacturing, and commercial supply, 3PBIOVIAN is equipped to offer comprehensive manufacturing services at all stages, encompassing Drug Substance and Drug Product. Manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland seamlessly support the diverse needs of clients, covering pre-clinical and clinical supply to full-scale commercial manufacturing.